亚盛医药（06855）2026年9月28日自愿公告披露，公司主席兼执行董事杨大俊博士于2026年9月23日至25日通过场内交易累计认购公司38,630股普通股，成交总金额约为115.71万港元，平均认购价格约29.95港元/股。\n\n本次增持后，按照香港法例第571章《证券及期货条例》第XV部的相关规定，杨大俊博士的总持股数量由62,531,624股增至62,570,254股，占公司已发行股本总额的比例由约16.68%增至约16.69%。\n\n公司称，杨大俊博士此举反映其对亚盛医药未来发展的信心。公告指出，本次增持已遵守香港联合交易所有限公司《证券上市规则》附录C3所载的董事进行证券交易的标准守则及公司内部相关政策。\n\n亚盛医药提醒全体股东及潜在投资者，在买卖公司证券时应保持审慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.